Eubiologics Co., Ltd.

Eubiologics Co., Ltd. is a South Korean biotechnology company dedicated to the development and manufacturing of microbial-based pharmaceuticals and vaccines. The primary function of Eubiologics lies in advancing public health through its innovative vaccine technologies aimed at preventing various infectious diseases. Notably, the company's product portfolio includes vaccines for cholera and other bacterial infections, highlighting its significant role in the pharmaceutical and healthcare sectors. Eubiologics is actively involved in research and development to expand its offerings and address unmet medical needs. Within the financial market, Eubiologics stands out as a key player in the biotech industry, contributing to the global efforts for disease prevention and health improvement. Its advancements in vaccine development reflect its commitment to fostering healthier societies and demonstrate its potential impact on both local and international healthcare landscapes.